About TriNetX
TriNetX is a company based in Cambridge (United States) founded in 2013 was acquired by The Carlyle Group in September 2020. TriNetX has raised $53 million across 2 funding rounds from investors including Mitsui & Co, The Carlyle Group and ITOCHU. The company has 95 employees as of December 31, 2022. TriNetX has completed 3 acquisitions, including Advera Health, Custodix and Insite Platform. TriNetX offers products and services including TriNetX LIVE™ and EVIDEX®. TriNetX operates in a competitive market with competitors including Medidata, Verily, Signant Health, Clinical Ink and WIRB-Copernicus Group, among others.
- Headquarter Cambridge, United States
- Employees 95 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Trinetx, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$53 M (USD)
in 2 rounds
-
Latest Funding Round
$40 M (USD), Series D
Mar 13, 2019
-
Investors
Mitsui & Co.
& 7 more
-
Employee Count
95
as on Dec 31, 2022
-
Investments & Acquisitions
Advera Health
& 2 more
-
Acquired by
The Carlyle Group
(Sep 21, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TriNetX
TriNetX offers a comprehensive portfolio of products and services, including TriNetX LIVE™ and EVIDEX®.
Platform for querying de-identified patient records and analytics.
Tool for detecting and managing drug safety signals.
People of TriNetX
Unlock access to complete
Unlock access to complete
Funding Insights of TriNetX
TriNetX has successfully raised a total of $53M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $40 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TriNetX
TriNetX has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Mitsui & Co, The Carlyle Group and ITOCHU.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital is focused on the life science sector.
|
Locked | Locked | Locked | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for TriNetX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TriNetX
TriNetX has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Advera Health, Custodix and Insite Platform.
Investment portfolio details for TriNetX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of clinical data management platform
|
Locked | Locked | 2015 | Locked | |
|
Provider of a SaaS based regulatory data analysis and pharmacovigilance platform for life science industry
|
Locked | Locked | 2010 | Locked | |
|
Clinical trial patient recruitment solutions are provided by Custodix.
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for TriNetX
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - TriNetX
Detailed financials for TriNetX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Trinetx Comparisons
Peer comparison for TriNetX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TriNetX
TriNetX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, Signant Health, Clinical Ink and WIRB-Copernicus Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| Locked | Locked | Locked |
AI-based solutions for health management are provided.
|
|
| Locked | Locked | Locked |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| Locked | Locked | Locked |
Paperless eSource and patient engagement solutions for clinical trials
|
|
| Locked | Locked | Locked |
Regulatory and ethical review services for clinical research are provided.
|
Detailed competitors of TriNetX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Trinetx
Complete news archive for TriNetX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TriNetX
TriNetX was founded in 2013 and raised its 1st funding round 1 year after it was founded.
TriNetX is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
TriNetX is a funded company, having raised a total of $53M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at TriNetX is 95.
TriNetX offers clinical trial management software for researchers and professionals. The company has developed tools like TriNetX Analyze that assist in analyzing clinical trial data, TriNetX Research that gives a comparative analysis of treatment and outcomes, TriNetX Analyze assist in analyzing medical reports for medication conflicts, and more. The TriNetX Network, allows researcherssponsors to analyze patient populations, refine clinical study assumptions, and ultimately locate the best clinical sites and successfully recruit patients to their study. It enables pharmaceutical companies, healthcare providers, and CROs to truly leverage patient data in a way that fosters collaboration and efficiency in clinical research to make a lasting impact on drug development and bring new therapies to market faster.
TriNetX offers TriNetX LIVE™ and EVIDEX®.
TriNetX has made 3 acquisitions, including Advera Health, Custodix, and Insite Platform.
TriNetX has 8 investors. Key investors include Mitsui & Co, The Carlyle Group, ITOCHU, Merck Global Health Innovation Fund, and ITV.